Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report released on Friday morning. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Price Performance

Arcadia Biosciences stock opened at $2.90 on Friday. The stock’s fifty day moving average price is $3.34 and its two-hundred day moving average price is $3.03. Arcadia Biosciences has a one year low of $1.85 and a one year high of $5.34. The firm has a market cap of $3.96 million, a PE ratio of -0.68 and a beta of 1.27.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.